[Irritable bowel syndrome with constipation and functional constipation in adults: Treatment (Part 2 of 2)].

Autor:	Mearin F; Coordinación de la GPC, Comité Roma de Trastornos Funcionales Intestinales, Asociación Española de Gastroenterología (AEG), Centro Médico Teknon, Barcelona, España., Ciriza C; Grupo de Trastornos Funcionales, Sociedad Española de Patología Digestiva (SEPD), Hospital Universitario Doce de Octubre, Madrid, España., Mínguez M; AEG y SEPD, Hospital Clínico Universitario, Universitat de Valencia, Valencia, España., Rey E; SEPD, Hospital Clínico Universitario San Carlos, Madrid, España., Mascort JJ; Secretaría Científica, Sociedad Española de Medicina de Familia y Comunitaria (semFYC), España. Electronic address: jmascort@semfyc.es., Peña E; Coordinación de Digestivo, Sociedad Española de Médicos de Atención Primaria (SEMERGEN), España., Cañones P; Coordinación de Digestivo, Sociedad Española de Médicos Generales y de Familia (SEMG), España., Júdez J; Departamento de Gestión del Conocimiento, SEPD, España.
Jazyk:	Spanish; Castilian
Zdroj:	Atencion primaria [Aten Primaria] 2017 Mar; Vol. 49 (3), pp. 177-194. Date of Electronic Publication: 2017 Feb 24.
DOI:	10.1016/j.aprim.2017.01.003
Abstrakt:	In this Clinical practice guide we examine the diagnostic and therapeutic management of adult patients with constipation and abdominal discomfort, at the confluence of the spectrum of irritable bowel syndrome and functional constipation. Both fall within the framework of functional intestinal disorders and have major personal, health and social impact, altering the quality of life of the patients affected. The former is a subtype of irritable bowel syndrome in which constipation and altered bowel habit predominate, often along with recurring abdominal pain, bloating and abdominal distension. Constipation is characterised by infrequent or hard-to-pass bowel movements, often accompanied by straining during defecation or the sensation of incomplete evacuation. There is no underlying organic cause in the majority of cases; it being considered a functional bowel disorder. There are many clinical and pathophysiological similarities between the two conditions, the constipation responds in a similar way to commonly used drugs, the fundamental difference being the presence or absence of pain, but not in an "all or nothing" way. The severity of these disorders depends not only on the intensity of the intestinal symptoms but also on other biopsychosocial factors: association of gastrointestinal and extraintestinal symptoms, degree of involvement, forms of perception and behaviour. Functional bowel disorders are diagnosed using the Rome criteria. This Clinical practice guide adapts to the Rome IV criteria published at the end of May 2016. The first part (96, 97, 98) examined the conceptual and pathophysiological aspects, alarm criteria, diagnostic test and referral criteria between Primary Care and Gastroenterology. This second part reviews all the available treatment alternatives (exercise, fluid ingestion, diet with soluble fibre-rich foods, fibre supplements, other dietary components, osmotic or stimulating laxatives, probiotics, antibiotics, spasmolytics, peppermint essence, prucalopride, linaclotide, lubiprostone, biofeedback, antdepressants, psychological treatment, acupuncture, enemas, sacral root neurostimulation and surgery), and practical recommendations are made for each. (Copyright © 2017 Elsevier España, S.L.U. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu